BlackRock Inc. boosted its stake in Proto Labs, Inc. (NYSE:PRLB) by 146,773.4% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 2,905,155 shares of the industrial products company’s stock after buying an additional 2,903,177 shares during the period. BlackRock Inc. owned about 10.98% of Proto Labs worth $148,453,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of PRLB. Victory Capital Management Inc. boosted its position in Proto Labs by 65.6% in the first quarter. Victory Capital Management Inc. now owns 1,974 shares of the industrial products company’s stock valued at $101,000 after buying an additional 782 shares during the last quarter. Ameritas Investment Partners Inc. bought a new stake in shares of Proto Labs during the first quarter worth about $109,000. UBS Group AG raised its stake in shares of Proto Labs by 128.0% in the first quarter. UBS Group AG now owns 2,603 shares of the industrial products company’s stock worth $133,000 after buying an additional 11,895 shares during the period. State of Alaska Department of Revenue raised its stake in shares of Proto Labs by 2.3% in the first quarter. State of Alaska Department of Revenue now owns 2,690 shares of the industrial products company’s stock worth $137,000 after buying an additional 60 shares during the period. Finally, SG Americas Securities LLC raised its stake in shares of Proto Labs by 27.1% in the first quarter. SG Americas Securities LLC now owns 2,830 shares of the industrial products company’s stock worth $145,000 after buying an additional 603 shares during the period.
Shares of Proto Labs, Inc. (PRLB) traded down 0.50% during trading on Friday, hitting $69.55. 187,599 shares of the stock were exchanged. The firm has a 50 day moving average price of $71.18 and a 200 day moving average price of $60.83. The firm has a market capitalization of $1.85 billion, a P/E ratio of 40.44 and a beta of 0.93. Proto Labs, Inc. has a 52 week low of $43.10 and a 52 week high of $75.55.
Proto Labs (NYSE:PRLB) last announced its quarterly earnings results on Thursday, July 27th. The industrial products company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.06. The company had revenue of $82.04 million for the quarter, compared to analyst estimates of $80.49 million. Proto Labs had a net margin of 14.59% and a return on equity of 11.75%. The firm’s revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.45 EPS. Analysts forecast that Proto Labs, Inc. will post $2.06 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by BNB Daily and is the property of of BNB Daily. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.baseball-news-blog.com/2017/08/19/blackrock-inc-purchases-2903177-shares-of-proto-labs-inc-nyseprlb-updated-updated-updated.html.
Several research firms recently issued reports on PRLB. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $67.00 price objective on shares of Proto Labs in a research note on Friday, July 28th. Zacks Investment Research lowered shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 28th. Dougherty & Co upgraded shares of Proto Labs from a “sell” rating to a “neutral” rating in a report on Tuesday, June 27th. Finally, TheStreet upgraded shares of Proto Labs from a “c+” rating to a “b-” rating in a report on Friday, May 5th. Four research analysts have rated the stock with a hold rating, The stock has a consensus rating of “Hold” and an average target price of $60.75.
In other Proto Labs news, VP Robert Bodor sold 741 shares of the business’s stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $73.84, for a total transaction of $54,715.44. Following the completion of the sale, the vice president now owns 17,319 shares in the company, valued at approximately $1,278,834.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Rainer Gawlick sold 833 shares of the company’s stock in a transaction on Monday, May 22nd. The stock was sold at an average price of $64.05, for a total transaction of $53,353.65. Following the completion of the sale, the director now owns 6,258 shares of the company’s stock, valued at approximately $400,824.90. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,833 shares of company stock worth $342,782. 7.78% of the stock is owned by corporate insiders.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.